Pfuhlmann, Katrin
Schriever, Sonja C.
Legutko, Beata
Baumann, Peter
Harrison, Luke
Kabra, Dhiraj G.
Baumgart, Emily Violette
Tschöp, Matthias H.
Garcia-Caceres, Cristina
Pfluger, Paul T.
Funding for this research was provided by:
Helmholtz-Gemeinschaft (Portfolio Program Metabolic Dysfunction, ICEMED 'Imaging and Curing Environmental Metabolic Diseases' Alliance, ICEMED 'Imaging and Curing Environmental Metabolic Diseases' Alliance, Helmholtz-Israel-Cooperation in Personalized Medicine, Personalized Medicine Initiative, Initiative and Networking Fund)
Alexander von Humboldt-Stiftung
Article History
Received: 21 August 2017
Accepted: 22 January 2018
First Online: 8 February 2018
Ethics approval
: All studies in mice were approved by and performed according to the guidelines of the State of Bavaria, Germany.
: Not applicable.
: Matthias Tschöp is a scientific advisor to Novo Nordisk and ERX.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.